Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/REGULUS-THERAPEUTICS-INC-46475580/news/Regulus-Therapeutics-gibt-die-Verabreichung-des-ersten-Patienten-in-der-dritten-Kohorte-der-klinisch-45225152/?utm_source=whatsapp&utm_medium=social&utm_campaign=share